Cargando…
Aquaporin 9 induction in human iPSC‐derived hepatocytes facilitates modeling of ornithine transcarbamylase deficiency
BACKGROUND AND AIMS: Patient‐derived human‐induced pluripotent stem cells (hiPSCs) differentiated into hepatocytes (hiPSC‐Heps) have facilitated the study of rare genetic liver diseases. Here, we aimed to establish an in vitro liver disease model of the urea cycle disorder ornithine transcarbamylase...
Autores principales: | Laemmle, Alexander, Poms, Martin, Hsu, Bernadette, Borsuk, Mariia, Rüfenacht, Véronique, Robinson, Joshua, Sadowski, Martin C., Nuoffer, Jean‐Marc, Häberle, Johannes, Willenbring, Holger |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295321/ https://www.ncbi.nlm.nih.gov/pubmed/34786702 http://dx.doi.org/10.1002/hep.32247 |
Ejemplares similares
-
Frequency and Pathophysiology of Acute Liver Failure in Ornithine Transcarbamylase Deficiency (OTCD)
por: Laemmle, Alexander, et al.
Publicado: (2016) -
Antepartum Ornithine Transcarbamylase Deficiency
por: Nakajima, Hitoshi, et al.
Publicado: (2014) -
Gene Mutation Analysis and Prenatal Diagnosis of the Ornithine Transcarbamylase (OTC) Gene in Two Families with Ornithine Transcarbamylase Deficiency
por: Li, Sitao, et al.
Publicado: (2018) -
Induced pluripotent stem cell technology as diagnostic tool in patients with suspected ornithine transcarbamylase deficiency lacking genetic confirmation
por: Ramosaj, Adhuresa, et al.
Publicado: (2023) -
Ornithine Transcarbamylase – From Structure to Metabolism: An Update
por: Couchet, Morgane, et al.
Publicado: (2021)